News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,873 Results
Type
Article (43150)
Company Profile (307)
Press Release (686403)
Multimedia
Podcasts (101)
Webinars (17)
Section
Business (210783)
Career Advice (2103)
Deals (36690)
Drug Delivery (111)
Drug Development (83232)
Employer Resources (175)
FDA (16694)
Job Trends (15463)
News (356776)
Policy (34060)
Tag
Academia (2603)
Accelerated approval (14)
Adcomms (25)
Allergies (114)
Alliances (51586)
ALS (130)
Alzheimer's disease (1539)
Antibody-drug conjugate (ADC) (178)
Approvals (16746)
Artificial intelligence (375)
Autoimmune disease (41)
Automation (23)
Bankruptcy (372)
Best Places to Work (11771)
BIOSECURE Act (20)
Biosimilars (140)
Biotechnology (188)
Bladder cancer (111)
Brain cancer (43)
Breast cancer (416)
Cancer (3357)
Cardiovascular disease (283)
Career advice (1769)
Career pathing (33)
CAR-T (207)
CDC (40)
Cell therapy (556)
Cervical cancer (27)
Clinical research (69050)
Collaboration (1217)
Company closure (4)
Compensation (845)
Complete response letters (43)
COVID-19 (2732)
CRISPR (73)
C-suite (489)
Cystic fibrosis (124)
Data (3753)
Decentralized trials (2)
Denatured (32)
Depression (85)
Diabetes (396)
Diagnostics (6577)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (168)
Drug pricing (152)
Drug shortages (31)
Duchenne muscular dystrophy (172)
Earnings (90254)
Editorial (46)
Employer branding (21)
Employer resources (151)
Events (117585)
Executive appointments (913)
FDA (18870)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1061)
Gene editing (154)
Generative AI (27)
Gene therapy (447)
GLP-1 (886)
Government (4706)
Grass and pollen (6)
Guidances (332)
Healthcare (19038)
HIV (42)
Huntington's disease (33)
IgA nephropathy (49)
Immunology and inflammation (196)
Immuno-oncology (14)
Indications (46)
Infectious disease (2926)
Inflammatory bowel disease (166)
Inflation Reduction Act (10)
Influenza (77)
Intellectual property (165)
Interviews (325)
IPO (16882)
IRA (55)
Job creations (4066)
Job search strategy (1496)
Kidney cancer (13)
Labor market (64)
Layoffs (549)
Leadership (24)
Legal (8407)
Liver cancer (84)
Longevity (12)
Lung cancer (481)
Lymphoma (245)
Machine learning (22)
Management (59)
Manufacturing (531)
MASH (113)
Medical device (13650)
Medtech (13667)
Mergers & acquisitions (20613)
Metabolic disorders (983)
Multiple sclerosis (113)
NASH (17)
Neurodegenerative disease (160)
Neuropsychiatric disorders (40)
Neuroscience (2382)
NextGen: Class of 2025 (6647)
Non-profit (4542)
Now hiring (53)
Obesity (482)
Opinion (255)
Ovarian cancer (111)
Pain (154)
Pancreatic cancer (143)
Parkinson's disease (202)
Partnered (24)
Patents (372)
Patient recruitment (264)
Peanut (55)
People (60073)
Pharmaceutical (91)
Pharmacy benefit managers (23)
Phase I (21394)
Phase II (30386)
Phase III (22743)
Pipeline (2430)
Policy (246)
Postmarket research (2655)
Preclinical (9136)
Press Release (68)
Prostate cancer (165)
Psychedelics (41)
Radiopharmaceuticals (261)
Rare diseases (549)
Real estate (6278)
Recruiting (68)
Regulatory (24008)
Reports (51)
Research institute (2386)
Resumes & cover letters (361)
Rett syndrome (11)
RNA editing (12)
RSV (55)
Schizophrenia (116)
Series A (176)
Series B (133)
Service/supplier (12)
Sickle cell disease (73)
Special edition (22)
Spinal muscular atrophy (151)
Sponsored (35)
Startups (3746)
State (2)
Stomach cancer (15)
Supply chain (88)
Tariffs (81)
The Weekly (67)
Vaccines (889)
Venture capital (59)
Weight loss (313)
Women's health (51)
Worklife (17)
Date
Today (185)
Last 7 days (506)
Last 30 days (2312)
Last 365 days (31376)
2025 (22106)
2024 (35774)
2023 (40634)
2022 (51802)
2021 (56336)
2020 (54799)
2019 (47410)
2018 (35779)
2017 (33139)
2016 (32665)
2015 (38621)
2014 (32518)
2013 (27633)
2012 (29735)
2011 (30487)
2010 (28500)
Location
Africa (788)
Alabama (69)
Alaska (7)
Arizona (268)
Arkansas (14)
Asia (41379)
Australia (6609)
California (8611)
Canada (2666)
China (804)
Colorado (361)
Connecticut (369)
Delaware (229)
Europe (88569)
Florida (1284)
Georgia (287)
Hawaii (2)
Idaho (60)
Illinois (697)
India (42)
Indiana (415)
Iowa (17)
Japan (267)
Kansas (116)
Kentucky (31)
Louisiana (16)
Maine (65)
Maryland (1145)
Massachusetts (6346)
Michigan (268)
Minnesota (508)
Mississippi (4)
Missouri (101)
Montana (29)
Nebraska (25)
Nevada (98)
New Hampshire (69)
New Jersey (2356)
New Mexico (29)
New York (2345)
North Carolina (1218)
North Dakota (8)
Northern California (3900)
Ohio (262)
Oklahoma (18)
Oregon (40)
Pennsylvania (1820)
Puerto Rico (17)
Rhode Island (41)
South America (1165)
South Carolina (44)
South Dakota (1)
Southern California (3307)
Tennessee (138)
Texas (1332)
United States (31476)
Utah (256)
Virginia (222)
Washington D.C. (75)
Washington State (720)
West Virginia (4)
Wisconsin (75)
729,873 Results for "acumen pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Acumen Pharmaceuticals to Participate in Upcoming September 2025 Investor Conferences
August 26, 2025
·
1 min read
Press Releases
Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights
August 12, 2025
·
13 min read
Press Releases
Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025
August 6, 2025
·
1 min read
Press Releases
Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer’s Disease
July 16, 2025
·
10 min read
Press Releases
Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference
May 8, 2025
·
1 min read
Press Releases
JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform
July 16, 2025
·
7 min read
Press Releases
Acumen Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Highlights
May 14, 2025
·
11 min read
Press Releases
Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
May 7, 2025
·
1 min read
Press Releases
Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’s Association International Conference (AAIC) 2025
July 29, 2025
·
6 min read
Business
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
Acumen Pharmaceuticals, Inc. reported financial results for the first quarter of 2024 and provided a business update.
May 14, 2024
·
12 min read
1 of 72,988
Next
